AKBA
Akebia Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.73
−0.11%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.42x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.03x
- Price / sales
- 0.92x
- Price / cash flow
- 4.83x
Enterprise value
- Enterprise value
- $99.3M
- EV / sales
- 0.45x
- EV / EBITDA
- -5.42x
- EV / EBIT
- -6.57x
- Market cap
- $200.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026